GSK released data from a Phase 3 trial evaluating the co-administration of Arexvy and Shingrix vaccines in adults 50+. The ...

The new, free vaccine, Beyfortus, will be available to children up to 24 months old through their health care provider or at ...

Often dismissed as just another common cold, RSV can be deadly, especially for infants and older people. Hannah and her twin ...

As the 2024-2025 respiratory virus season gets under way, statewide infectious disease experts urge everyone in Oregon to ...

Global Respiratory Syncytial Virus Therapeutics Market was valued at approximately USD 5.88 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 12.82% over the forecast ...

The Nunavut government says it will provide immunization against respiratory syncytial virus to all infants in the territory ...

GSK (GSK) reached the main goal in a Phase 3 trial for its RSV shot, Arexvy co--administered with Shingles vaccine Shingrix.

CHICAGO, CA, UNITED STATES, September 16, 2024 /EINPresswire / -- The global respiratory syncytial virus (RSV) <a target=_blank href=htt ...

The Oregon Health Authority urges residents to stay up to date on vaccinations, as RSV season is difficult to forecast.

The California Department of Public Health is encouraging all Californians to get vaccinated this season to protect ...

The convergence of genetic engineering and artificial intelligence brings both the potential to revolutionize medicine and ...